BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gómez-García M, Cabello-Tapia MJ, Sánchez-Capilla AD, Teresa-Galván JD, Redondo-Cerezo E. Thiopurines related malignancies in inflammatory bowel disease: Local experience in Granada, Spain. World J Gastroenterol 2013; 19(30): 4877-4886 [PMID: 23946592 DOI: 10.3748/wjg.v19.i30.4877]
URL: https://www.wjgnet.com/1007-9327/full/v19/i30/4877.htm
Number Citing Articles
1
Anastasia Mala, Kalliopi Foteinogiannopoulou, Ioannis E Koutroubakis. Solid extraintestinal malignancies in patients with inflammatory bowel diseaseWorld Journal of Gastrointestinal Oncology 2021; 13(12): 1956-1980 doi: 10.4251/wjgo.v13.i12.1956
2
Steven C Lin, Alex Goldowsky, Konstantinos Papamichael, Adam S Cheifetz. The Treatment of Inflammatory Bowel Disease in Patients With a History of MalignancyInflammatory Bowel Diseases 2019; 25(6): 998 doi: 10.1093/ibd/izy376
3
Manuel Barreiro-de Acosta, Alberto Molero, Esther Artime, Silvia Díaz-Cerezo, Luis Lizán, Héctor David de Paz, María Dolores Martín-Arranz. Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn’s disease) in Spain: A Systematic ReviewAdvances in Therapy 2023; 40(5): 1975 doi: 10.1007/s12325-023-02473-6
4
Cho-Hsun Hsieh, Yi-Wei Huang, Tsen-Fang Tsai. Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a ReviewDermatology and Therapy 2022; 12(4): 835 doi: 10.1007/s13555-022-00713-1
5
Jianfeng Gong, Lijing Zhu, Zhen Guo, Yi Li, Weiming Zhu, Ning Li, Jieshou Li, Christopher R. Weber. Use of Thiopurines and Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Diseases: A Meta-AnalysisPLoS ONE 2013; 8(11): e81487 doi: 10.1371/journal.pone.0081487
6
Florian Poullenot, Philippe Seksik, Laurent Beaugerie, Aurélien Amiot, Maria Nachury, Vered Abitbol, Carmen Stefanescu, Catherine Reenaers, Mathurin Fumery, Anne-Laure Pelletier, Stephane Nancey, Laurent Peyrin-Biroulet, Arnaud Bourreille, Xavier Hébuterne, Hedia Brixi, Guillaume Savoye, Nelson Lourenço, Romain Altwegg, Anthony Buisson, Christine Cazelles-Boudier, Antoine Racine, Julien Vergniol, David Laharie. Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent MalignancyInflammatory Bowel Diseases 2016; 22(6): 1362 doi: 10.1097/MIB.0000000000000741
7
Hsien‐Chung Yu. Primary colonic lymphoma in patients with inflammatory bowel disease: Is it treatment‐ or disease‐related adverse event?Advances in Digestive Medicine 2020; 7(4): 177 doi: 10.1002/aid2.13263
8
Vito Annese, Laurent Beaugerie, Laurence Egan, Livia Biancone, Claus Bolling, Christian Brandts, Daan Dierickx, Reinhard Dummer, Gionata Fiorino, Jean Marc Gornet, Peter Higgins, Konstantinos H Katsanos, Loes Nissen, Gianluca Pellino, Gerhard Rogler, Franco Scaldaferri, Edyta Szymanska, Rami Eliakim. European Evidence-based Consensus: Inflammatory Bowel Disease and MalignanciesJournal of Crohn's and Colitis 2015; 9(11): 945 doi: 10.1093/ecco-jcc/jjv141
9
Joshua W. Hagen, Melissa A. Pugliano-Mauro. Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the LiteratureDermatologic Surgery 2018; 44(4): 469 doi: 10.1097/DSS.0000000000001455
10
Hannah Gordon, Livia Biancone, Gionata Fiorino, Konstantinos H Katsanos, Uri Kopylov, Eman Al Sulais, Jordan E Axelrad, Karthiha Balendran, Johan Burisch, Lissy de Ridder, Lauranne Derikx, Pierre Ellul, Thomas Greuter, Marietta Iacucci, Caroline Di Jiang, Christina Kapizioni, Konstantinos Karmiris, Julien Kirchgesner, David Laharie, Triana Lobatón, Tamás Molnár, Nurulamin M Noor, Rohit Rao, Simone Saibeni, Michael Scharl, Stephan R Vavricka, Tim Raine. ECCO Guidelines on Inflammatory Bowel Disease and MalignanciesJournal of Crohn's and Colitis 2023; 17(6): 827 doi: 10.1093/ecco-jcc/jjac187
11
M. J. Lu, X. Y. Qiu, X. Q. Mao, X. T. Li, H. J. Zhang. Systematic review with meta‐analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics 2018; 47(3): 318 doi: 10.1111/apt.14436
12
Shao‐Zhuo Huang, Zhi‐Cheng Liu, Wei‐Xin Liao, Jun‐Xiao Wei, Xiao‐Wen Huang, Chen Yang, Yu‐Han Xia, Lu Li, Chao Ye, Shi‐Xue Dai. Risk of skin cancers in thiopurines‐treated and thiopurines‐untreated patients with inflammatory bowel disease: A systematic review and meta‐analysisJournal of Gastroenterology and Hepatology 2019; 34(3): 507 doi: 10.1111/jgh.14533
13
Zhehui Zhu, Zubing Mei, Yuegui Guo, Guanghui Wang, Tingyu Wu, Ximao Cui, Zhenyu Huang, Yilian Zhu, Dongpeng Wen, Jinglve Song, Hailan He, Weimin Xu, Long Cui, Chenying Liu. Reduced Risk of Inflammatory Bowel Disease-associated Colorectal Neoplasia with Use of Thiopurines: a Systematic Review and Meta-analysisJournal of Crohn's and Colitis 2018; 12(5): 546 doi: 10.1093/ecco-jcc/jjy006
14
Alessandro Massano, Luisa Bertin, Fabiana Zingone, Andrea Buda, Pierfrancesco Visaggi, Lorenzo Bertani, Nicola de Bortoli, Matteo Fassan, Marco Scarpa, Cesare Ruffolo, Imerio Angriman, Cristina Bezzio, Valentina Casini, Davide Giuseppe Ribaldone, Edoardo Vincenzo Savarino, Brigida Barberio. Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature ReviewCancers 2023; 15(15): 3824 doi: 10.3390/cancers15153824
15
Hanna M J L Hazenberg, Nanne K H de Boer, Chris J J Mulder, Stijn H Mom, Ad A van Bodegraven, Greetje J Tack. Neoplasia and Precursor Lesions of the Female Genital Tract in IBD: Epidemiology, Role of Immunosuppressants, and Clinical ImplicationsInflammatory Bowel Diseases 2018; 24(3): 510 doi: 10.1093/ibd/izx062